1. Home
  2. VTEX vs SLDB Comparison

VTEX vs SLDB Comparison

Compare VTEX & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VTEX

VTEX

VTEX

HOLD

Current Price

$4.09

Market Cap

697.3M

Sector

Technology

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$8.40

Market Cap

498.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTEX
SLDB
Founded
1999
2013
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
697.3M
498.6M
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
VTEX
SLDB
Price
$4.09
$8.40
Analyst Decision
Buy
Strong Buy
Analyst Count
6
11
Target Price
$5.97
$16.36
AVG Volume (30 Days)
1.1M
1.0M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.97
EPS
N/A
N/A
Revenue
N/A
$8,094,000.00
Revenue This Year
$12.72
N/A
Revenue Next Year
$9.83
N/A
P/E Ratio
$43.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.84
$2.51
52 Week High
$6.82
$8.87

Technical Indicators

Market Signals
Indicator
VTEX
SLDB
Relative Strength Index (RSI) 60.11 61.77
Support Level $3.92 $5.16
Resistance Level $4.21 N/A
Average True Range (ATR) 0.14 0.58
MACD -0.01 0.06
Stochastic Oscillator 70.24 79.07

Price Performance

Historical Comparison
VTEX
SLDB

About VTEX VTEX

Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. The VTEX platform is designed to be composable and complete, enabling its customers to seamlessly implement, optimize, test, and expand both B2C and B2B digital experiences. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: